OBJECTIVES: Improving Access to Psychological Therapies (IAPT) is a national-level dissemination programme for provision of evidence-based psychological treatments for anxiety and depression in the United Kingdom. This paper sought to review and meta-analyse practice-based evidence arising from the programme. DESIGN: A pre-registered (CRD42018114796) systematic review and meta-analysis. METHODS: A random effects meta-analysis was performed only on the practice-based IAPT studies (i.e. excluding the clinical trials). Subgroup analyses examined the potential influence of particular methodologies, treatments, populations, and target conditions. Sensitivity analyses investigated potential sources of heterogeneity and bias. RESULTS: The systematic review identified N = 60 studies, with N = 47 studies suitable for meta-analysis. The primary meta-analysis showed large pre-post treatment effect sizes for depression (d = 0.87, 95% CI [0.78-0.96], p < .0001) and anxiety (d = 0.88, 95% CI [0.79-0.97], p < .0001), and a moderate effect on functional impairment (d = 0.55, 95% CI [0.48-0.61], p < .0001). The methodological features of studies influenced ESs (e.g., such as whether intention-to-treat or completer analyses were employed). CONCLUSIONS: Current evidence suggests that IAPT enables access to broadly effective evidence-based psychological therapies for large numbers of patients. The limitations of the review and the clinical and methodological implications are discussed. PRACTITIONER POINTS: IAPT interventions are associated with large pre-post treatment effect sizes in depression and anxiety measures. IAPT interventions are associated with moderate treatment effect sizes with regards to work and social adjustment. A reduction in dropout and also the prevention of post-treatment relapse via the offer of follow-up support are important areas for future development.
OBJECTIVES: Improving Access to Psychological Therapies (IAPT) is a national-level dissemination programme for provision of evidence-based psychological treatments for anxiety and depression in the United Kingdom. This paper sought to review and meta-analyse practice-based evidence arising from the programme. DESIGN: A pre-registered (CRD42018114796) systematic review and meta-analysis. METHODS: A random effects meta-analysis was performed only on the practice-based IAPT studies (i.e. excluding the clinical trials). Subgroup analyses examined the potential influence of particular methodologies, treatments, populations, and target conditions. Sensitivity analyses investigated potential sources of heterogeneity and bias. RESULTS: The systematic review identified N = 60 studies, with N = 47 studies suitable for meta-analysis. The primary meta-analysis showed large pre-post treatment effect sizes for depression (d = 0.87, 95% CI [0.78-0.96], p < .0001) and anxiety (d = 0.88, 95% CI [0.79-0.97], p < .0001), and a moderate effect on functional impairment (d = 0.55, 95% CI [0.48-0.61], p < .0001). The methodological features of studies influenced ESs (e.g., such as whether intention-to-treat or completer analyses were employed). CONCLUSIONS: Current evidence suggests that IAPT enables access to broadly effective evidence-based psychological therapies for large numbers of patients. The limitations of the review and the clinical and methodological implications are discussed. PRACTITIONER POINTS: IAPT interventions are associated with large pre-post treatment effect sizes in depression and anxiety measures. IAPT interventions are associated with moderate treatment effect sizes with regards to work and social adjustment. A reduction in dropout and also the prevention of post-treatment relapse via the offer of follow-up support are important areas for future development.
Authors: Chris Gaskell; Melanie Simmonds-Buckley; Stephen Kellett; C Stockton; Erin Somerville; Emily Rogerson; Jaime Delgadillo Journal: Adm Policy Ment Health Date: 2022-10-06
Authors: Dan J Stein; Steven J Shoptaw; Daniel V Vigo; Crick Lund; Pim Cuijpers; Jason Bantjes; Norman Sartorius; Mario Maj Journal: World Psychiatry Date: 2022-10 Impact factor: 79.683
Authors: Ángel Aguilera-Martín; Mario Gálvez-Lara; Fátima Cuadrado; Eliana Moreno; Francisco García-Torres; José F Venceslá; Jorge Corpas; Francisco J Jurado-González; Roger Muñoz-Navarro; César González-Blanch; Paloma Ruiz-Rodríguez; Sara Barrio-Martínez; Maider Prieto-Vila; María Carpallo-González; Antonio Cano-Vindel; Juan A Moriana Journal: BMC Psychiatry Date: 2022-02-09 Impact factor: 3.630
Authors: Lida Efstathopoulou; Grace Jagger; Jules Mackenzie; Kathryn Faulkner; Trish Barker-Barrett; Rory Cameron; Adam P Wagner; Jesus Perez Journal: Health Res Policy Syst Date: 2022-02-05
Authors: Daniel B Fassnacht; Kathina Ali; Joep van Agteren; Matthew Iasiello; Teri Mavrangelos; Gareth Furber; Michael Kyrios Journal: JMIR Ment Health Date: 2022-05-05
Authors: Nick Firth; Michael Barkham; Jaime Delgadillo; Kai Allery; Jonathan Woodward; Alicia O'Cathain Journal: Adm Policy Ment Health Date: 2021-11-27